K+ Channel Expression in Pancreatic Beta-Cells
K+ Channel Expression in Pancreatic Beta-Cells
批准号:
8006768
负责人:
Louis H. Philipson
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-04 至 2010-04-30
关键词:
AblationAction PotentialsAddressAffectAgonistCalcium SignalingCalcium-Activated Potassium ChannelCell membraneCellsComputer SimulationCouplingCyclic AMP-Dependent Protein KinasesDataDiabetes MellitusDominant-Negative MutationElectric CapacitanceExhibitsFatty acid glycerol estersGenerationsGlucoseHealthHumanHypoglycemiaInsulin ResistanceIslets of LangerhansKnock-outKv2.1 channelMeasurementMeasuresMediatingMembraneMembrane PotentialsMetabolismModelingMolecularMolecular TargetMovementMusPathogenesisPhosphorylationPhysiologicalPlayPotassium ChannelProductionPropertyPublishingRegulationRelative (related person)RestRodentRoleStructure of beta Cell of isletTestingTetraethylammoniumarachidonatebaseblood glucose regulationchannel blockersdiabeticfeedingimaging modalityinsulin granuleinsulin secretionisletmathematical modelmouse modelnovelpotassium ionpublic health relevanceresponsevoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this revised proposal is to elucidate the molecular mechanisms coupling electrical excitability of ¿-cells to glucose-induced insulin secretion (GSIS) in normal and diabetic states. We seek to test hypotheses concerning the role of voltage- dependent K+ (Kv) channels in regulating electrical activity and changes in intracellular free Ca2+ concentration ([Ca2+]i) that triggers GSIS. Once metabolism leads to closure of KATP channels generating action potentials (APs), Kv channels serve a distinct role in repolarizing the ¿-cell membrane, resulting in Ca2+ transients necessary for insulin secretion. Incretin agonists used to treat diabetes reduce Kv currents by a PKA- dependent mechanism, but the identity of the Kv channels involved remains undefined. The Kv channel Kv2.1 is the predominant Kv channel in ¿-cells, thought to be a critical channel for ¿-cell membrane repolarization. We found that Kv2.1-/- mice, a new knockout model, exhibit abnormal glucose homeostasis with a significant resting hypoglycemia and increased insulin secretion in response to physiological steps in glucose concentration. The islets have wide and aberrant action potentials (APs). Surprisingly the Kv2.1-/- islets remain sensitive to tetraethylammonium, a blocker of Kv channels and Ca2+-activated K+ channels (KCa). These results reveal that other K+ channels participate in membrane repolarization and generation of APs, and could be targets for regulation. We propose to study the properties of these Kv currents not previously studied in normal mouse models in wild type and Kv2.1-/- mice with the following two specific aims: Aim 1. To define mechanisms underlying regulation of insulin secretion and calcium signaling by Kv channels. Aim 2. To define the molecular identity of repolarizing K+ channels expressed in ¿-cells and understand the role they play in ¿-cell excitation-secretion coupling. The results of these studies will enhance our understanding of the importance of Kv channels in insulin secretion and their role in the pathogenesis and potential treatment of diabetes. PUBLIC HEALTH RELEVANCE: Diabetes Mellitus is an important health problem, caused by abnormal insulin secretion relative to the degree of insulin resistance leading to numerous complications. This project addresses important biophysical aspects of the regulation of insulin secretion focusing on how potassium ion movement in and out of the cell controls insulin secretion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus
-
批准号:10660917
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2018
-
负责人:Louis H. Philipson
-
依托单位:
Chicagoland Diabetes TrialNet Clinical Center
-
批准号:9414298
-
项目类别:
-
资助金额:$4.92万
-
财政年份:2014
-
负责人:Louis H. Philipson
-
依托单位:
Chicagoland Diabetes TrialNet Clinical Center
-
批准号:9065721
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2014
-
负责人:Louis H. Philipson
-
依托单位:
Core A: Islet Cell Biology Core
-
批准号:8626377
-
项目类别:
-
资助金额:$18.78万
-
财政年份:2014
-
负责人:Louis H. Philipson
-
依托单位:
Chicagoland Diabetes TrialNet Clinical Center
-
批准号:8774722
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2014
-
负责人:Louis H. Philipson
-
依托单位:
Core A: Islet Cell Biology Core
-
批准号:8446544
-
项目类别:
-
资助金额:$22.86万
-
财政年份:2013
-
负责人:Louis H. Philipson
-
依托单位:
Diabetes Research and Training Center
-
批准号:7500638
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2006
-
负责人:Louis H. Philipson
-
依托单位:
ISLET CELL BIOLOGY CORE
-
批准号:7660174
-
项目类别:
-
资助金额:$11.53万
-
财政年份:2005
-
负责人:Louis H. Philipson
-
依托单位:
INSULIN SECREETION IN ISLET CELL TRANSPLANT RECIPIENTS
-
批准号:7201053
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2005
-
负责人:Louis H. Philipson
-
依托单位:
Pediatric Endocrinology Research Training Grant
-
批准号:8867222
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2004
-
负责人:Louis H. Philipson
-
依托单位:
Pediatric Endocrinology Research Training Grant
-
批准号:9284473
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2004
-
负责人:Louis H. Philipson
-
依托单位:
Pediatric Endocrinology Research Training Grant
-
批准号:8665749
-
项目类别:
-
资助金额:$12.47万
-
财政年份:2004
-
负责人:Louis H. Philipson
-
依托单位:
ISLET CELL BIOLOGY CORE
-
批准号:7660134
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2004
-
负责人:Louis H. Philipson
-
依托单位:
IMAGING BETA CELL FUNCTION WITH BIOSENSORS
-
批准号:6666973
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2002
-
负责人:Louis H. Philipson
-
依托单位:
IMAGING BETA CELL FUNCTION WITH BIOSENSORS
-
批准号:6928530
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2002
-
负责人:Louis H. Philipson
-
依托单位:
IMAGING BETA CELL FUNCTION WITH BIOSENSORS
-
批准号:6788100
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2002
-
负责人:Louis H. Philipson
-
依托单位:
IMAGING BETA CELL FUNCTION WITH BIOSENSORS
-
批准号:6576344
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2002
-
负责人:Louis H. Philipson
-
依托单位:
IMAGING BETA CELL FUNCTION WITH BIOSENSORS
-
批准号:7394833
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:Louis H. Philipson
-
依托单位:
CORE--ANIMAL AND CELLULAR LABORATORY
-
批准号:6564280
-
项目类别:
-
资助金额:$14.67万
-
财政年份:2001
-
负责人:Louis H. Philipson
-
依托单位:
CORE--ANIMAL AND CELLULAR LABORATORY
-
批准号:6410328
-
项目类别:
-
资助金额:$14.67万
-
财政年份:2000
-
负责人:Louis H. Philipson
-
依托单位:
海外基金